Shell Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7K | Sell |
9,137
-7,847
| -46% | -$6.01K | ﹤0.01% | 1257 |
|
|
2025
Q1 | $14K | Sell |
16,984
-570
| -3% | -$470 | ﹤0.01% | 1240 |
|
|
2024
Q4 | $24K | Hold |
17,554
| – | – | ﹤0.01% | 1235 |
|
|
2024
Q3 | $18K | Buy |
+17,554
| New | +$18K | ﹤0.01% | 1240 |
|
|
2024
Q1 | $26K | Sell |
15,069
-1,015
| -6% | -$1.75K | ﹤0.01% | 1218 |
|
|
2023
Q4 | $54K | Sell |
16,084
-4,830
| -23% | -$16.2K | ﹤0.01% | 1163 |
|
|
2023
Q3 | $78K | Sell |
20,914
-329
| -2% | -$1.23K | ﹤0.01% | 1129 |
|
|
2023
Q2 | $91K | Sell |
21,243
-122
| -0.6% | -$523 | ﹤0.01% | 1138 |
|
|
2023
Q1 | $146K | Sell |
21,365
-75
| -0.3% | -$513 | 0.01% | 1022 |
|
|
2022
Q4 | $170K | Sell |
21,440
-4,353
| -17% | -$34.5K | 0.01% | 1005 |
|
|
2022
Q3 | $248K | Sell |
25,793
-6,760
| -21% | -$65K | 0.01% | 922 |
|
|
2022
Q2 | $236K | Buy |
32,553
+55
| +0.2% | +$399 | 0.01% | 1067 |
|
|
2022
Q1 | $420K | Sell |
32,498
-4,809
| -13% | -$62.2K | 0.01% | 891 |
|
|
2021
Q4 | $595K | Buy |
37,307
+179
| +0.5% | +$2.86K | 0.01% | 821 |
|
|
2021
Q3 | $597K | Sell |
37,128
-1,600
| -4% | -$25.7K | 0.01% | 785 |
|
|
2021
Q2 | $536K | Buy |
38,728
+2,100
| +6% | +$29.1K | 0.01% | 879 |
|
|
2021
Q1 | $535K | Buy |
36,628
+18,859
| +106% | +$275K | 0.01% | 821 |
|
|
2020
Q4 | $309K | Buy |
+17,769
| New | +$309K | 0.01% | 994 |
|